Description

Pyrido[3,2-E]Pyrrolo[1,2-A]Pyrazin-6(5H)-One, 6A,7,8,9-Tetrahydro- (9Ci) is a complex heterocyclic organic compound that serves as a crucial advanced pharmaceutical intermediate and a versatile scaffold in medicinal chemistry. Its unique fused-ring structure makes it a valuable building block for the synthesis of novel bioactive molecules, particularly in the development of central nervous system (CNS) and oncology therapeutics. This high-purity intermediate is essential for research institutions, contract development and manufacturing organizations (CDMOs), and pharmaceutical companies engaged in the discovery and synthesis of new chemical entities (NCEs).

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the multi-step production of active pharmaceutical ingredients (APIs) with potential neurological or anticancer activity.
• Medicinal Chemistry Research: Used as a core scaffold or building block for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Organic Synthesis: Employed in academic and industrial research for the development of novel heterocyclic compounds and complex molecular architectures.
• Drug Discovery Programs: Integral to the synthesis of candidate drug molecules targeting specific receptors or enzymes, particularly within the CNS and oncology spaces.
• Chemical Biology Probes: Serves as a starting material for creating specialized probes used to study biological pathways and mechanisms of disease.

Basic Information

Item	Details
Product Name	Pyrido[3,2-E]Pyrrolo[1,2-A]Pyrazin-6(5H)-One, 6A,7,8,9-Tetrahydro- (9Ci)
CAS No.	91622-91-2
Molecular Formula	C11H10N2O
Molecular Weight	186.21 g/mol
Synonyms	6a,7,8,9-Tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-one; 5H-Pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6-one, 6a,7,8,9-tetrahydro-; Tetrahydro-pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6-one; 91622-91-2; Pyrrolo[1,2-a]pyrazine, pyrido[3,2-e] derivative; 6a,7,8,9-Tetrahydro-5H-pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6-one
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Each batch undergoes comprehensive analytical characterization, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. We provide a detailed Certificate of Analysis (COA) with every shipment, ensuring traceability and compliance with your research or cGMP-grade requirements. Specifications are designed to meet the exacting standards of pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic; therefore, containers should be kept tightly sealed in a dry environment to prevent moisture uptake.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.